By KidneyDiseaseMS.com Health Research Team | January 31, 2026
Understanding the true cost of tirzepatide treatment through MEDVi requires looking beyond headline prices. We've put together a complete pricing analysis that covers introductory rates, refill costs, hidden fees, and how MEDVi's tirzepatide pricing compares to alternatives in today's telehealth weight loss market.
If you're evaluating MEDVi for the first time, our affordable GLP-1 analysis provides important background on the platform's overall pricing philosophy.
Current MEDVi Tirzepatide Pricing Structure
MEDVi operates on a month-to-month subscription model with no long-term contracts. However, pricing isn't as straightforward as a single monthly fee. Here's the complete breakdown based on current platform listings:
Compounded Tirzepatide Injections:
First month starts at $279-$349, depending on dose requirements and formulation. This introductory price includes physician evaluation, personalized treatment plan, metabolic report, one-on-one guidance, medication supply, and shipping. Some patients report the first month at the lower end of this range, while others pay closer to $349.
Monthly refills range from $399-$499. The variation depends on your prescribed dose. As you titrate up to higher doses for better results, pricing typically increases. This dose-dependent pricing isn't unique to MEDVi but catches some patients off guard.
Compounded Tirzepatide Tablets:
Daily dissolvable tablets start at $279 for the first month. Refill pricing should be confirmed directly with customer service, as it varies based on formulation. Tablets generally cost more than injections across the industry due to different compounding requirements.
Annual Cost Projections
To help you budget realistically, here are projected annual costs at different price points:
Conservative Estimate (Lower Dosing): First year would run approximately $4,668 ($279 first month plus eleven months at $399). Subsequent years at the same dose would be $4,788 annually.
Higher Dose Estimate: First year at maximum pricing would be approximately $5,838 ($349 first month plus eleven months at $499). This assumes you reach and maintain the higher dose tier throughout the year.
Most patients fall somewhere between these estimates, especially during the first year when you're gradually titrating up from starting doses.
How MEDVi Tirzepatide Compares to Alternatives
Context matters when evaluating these prices. Analysis of the telehealth GLP-1 market shows MEDVi's compounded tirzepatide pricing falls within the industry range, though it sits toward the higher end.
Brand-Name Tirzepatide (Mounjaro/Zepbound): Retail prices without insurance typically exceed $1,000-$1,500 monthly. Most insurance plans don't cover weight loss medications, and even with coverage, copays can be substantial. MEDVi doesn't offer brand-name tirzepatide products.
Competing Telehealth Platforms: The compounded tirzepatide market generally prices between $350-$500 monthly for refills. Some platforms advertise lower introductory prices but charge comparable refill rates. Direct price comparison should account for what's included (some charge separately for consultations or shipping).
MEDVi Semaglutide vs. Tirzepatide: MEDVi's compounded semaglutide program costs quite a bit less ($179 first month, $299 refills). Patients choosing tirzepatide pay a premium of roughly $100-$200 monthly for the dual-action medication. Whether that premium is worth it depends on individual response and weight loss goals.
What's Included (And What Isn't)
MEDVi's pricing is marketed as “all-inclusive” for core services, but here's what's actually covered:
Included in Monthly Cost: Licensed physician evaluation through OpenLoop Health network, personalized treatment plan development, metabolic analysis reporting, one-on-one provider guidance, monthly medication supply, standard shipping, unlimited messaging with clinical team, and 24/7 support access.
Not Covered: Lab testing isn't automatically included for all patients. MEDVi only requires labs when your medical history indicates necessity (thyroid issues, kidney problems, diabetes, etc.). When labs are needed, MEDVi covers the cost and directs you to Quest Diagnostics. Brand-name medications aren't covered under standard pricing—Ozempic access lists separately at $1,999 monthly when available.
Insurance and Payment Considerations
MEDVi operates exclusively on a cash-pay model. The platform doesn't accept insurance for compounded medications, and MEDVi-affiliated providers are considered out-of-network for all insurance plans. You're responsible for 100% of program costs.
Medicare and Medicaid aren't accepted. If you have government insurance, you'll need to pay entirely out-of-pocket.
HSA/FSA Eligibility: MEDVi marketing indicates HSA and FSA payments may be accepted. Under IRS guidelines, prescription medications and medical services ordered by licensed providers generally qualify as eligible expenses. However, final eligibility depends on your specific plan administrator. Confirm with your HSA/FSA provider before using these funds.
Cancellation and Refund Policy
The month-to-month structure means you can cancel anytime without penalty. However, refund eligibility depends on several factors:
If you cancel before medication is prepared or shipped, you may be eligible for a refund minus consultation fees. Once medication is shipped, refunds become more limited. Consumer protection analysis suggests reviewing the full cancellation terms before enrollment.
MEDVi offers a weight loss guarantee: if you follow the program for five months without achieving weight loss, you may qualify for a refund minus 25% doctor consultation fees. The specific conditions for this guarantee should be confirmed in writing.
Price Optimization Strategies
If you're committed to tirzepatide but cost is a concern, consider these approaches:
Start with Semaglutide: Some patients begin with MEDVi's lower-cost semaglutide program ($299/month refills) and switch to tirzepatide if results plateau. This approach reduces initial costs while you assess how your body responds to GLP-1 therapy.
Discuss Dosing Strategy: Higher doses don't always mean better results for every patient. Work with your provider to find the minimum effective dose, which keeps costs at the lower end of the pricing range.
Compare Total Value: Some competing platforms advertise lower monthly prices but charge separately for consultations, shipping, or provider follow-ups. Calculate total annual cost including all fees before switching.
Red Flags to Watch For
Patient reviews reveal several pricing-related issues to monitor:
Some patients report being surprised by price increases after the first month. Always confirm refill pricing in writing before enrollment. Others mention being charged for months when they hadn't received medication due to shipping delays. Keep records of payment dates and delivery dates.
A few reviewers describe difficulty getting refunds after cancellation. Document all communications and understand the refund policy thoroughly before providing payment information.
Is MEDVi Tirzepatide Worth the Cost?
The value calculation depends on your specific situation. Tirzepatide produces approximately 6-7% greater weight loss than semaglutide based on clinical research findings. For a 200-pound person, that's potentially 12-14 additional pounds lost over a year.
At MEDVi's pricing, the tirzepatide premium over semaglutide runs roughly $1,200-$2,400 annually. Whether enhanced results justify that premium depends on your weight loss goals, budget constraints, and how your body responds to each medication.
For patients who haven't tried GLP-1 medications before, starting with the lower-cost semaglutide option might make sense. If you've already tried semaglutide with limited success, tirzepatide's dual mechanism offers a clinically validated alternative worth the premium.
This pricing analysis is current as of January 2026 and subject to change. Always verify current pricing directly with MEDVi before making enrollment decisions. This content is informational only and doesn't constitute financial or medical advice.
Frequently Asked Questions About MEDVi Tirzepatide Costs
Why does MEDVi tirzepatide cost more than semaglutide? Tirzepatide's dual-action mechanism (GLP-1 and GIP) makes it more complex and expensive to compound than single-receptor semaglutide. The raw ingredients cost more, and compounding requires additional quality controls. This pricing reflects industry-wide trends, not just MEDVi's markup.
Can I use my credit card rewards or cash-back for MEDVi payments? Yes, MEDVi accepts standard credit and debit card payments through Stripe. You can earn whatever rewards your card offers on these purchases, which might offset some costs if you're using a high-reward card.
What's the cheapest way to get tirzepatide through MEDVi? The most cost-effective approach is staying on lower doses if they're working for you. Higher doses mean higher prices. Also, watch for promotional pricing—MEDVi occasionally offers discounts on first months. Some patients start with semaglutide and only switch to tirzepatide if needed.
Does MEDVi offer payment plans or financing? Based on current information, MEDVi operates on a month-to-month cash-pay basis without traditional financing options. HSA and FSA funds may help manage costs if your plan administrator approves these purchases.
What happens to pricing if tirzepatide goes off the FDA shortage list? This is uncertain. Brand-name competition could affect compounded medication pricing, but the regulatory landscape around compounding during and after shortages remains in flux. Current pricing shouldn't be assumed to remain stable indefinitely.
Leave a Reply